Zemcelpro® (UM171 Cell Therapy) licensing and supply agreements announced for Europe
MONTREAL, Nov. 9, 2026 /PRNewswire/ — ExCellThera Inc. (“ExCellThera”), a global leader in blood stem cell expansion and metabolic fitness technologies and parent company of Cordex Biologics (“Cordex”), today announced

